The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

One of the most durable, and often underappreciated, drivers of earnings quality among MedTech companies is a favorable ...

A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

In recent days, Boston Scientific has drawn upbeat commentary from Wall Street, with analysts citing strong demand across ...

Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 ...

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers ...